Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.6043
H.R.6043: Fair Accountability and Innovative Research Drug Pricing Act of 2016
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Sept. 15, 2016
- Latest Major Action Sept. 15, 2016
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
18 (All Democrats)
Bill Summary
Fair Accountability and Innovative Research Drug Pricing Act of 2016 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the price of a drug over a 12-month period. Reports are required for prescription drugs and drugs commonly administered in hospitals, except...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Sept. 15, 2016 |
Referred to the House Committee on Energy and Commerce.
|
Sept. 15, 2016 |
Introduced in the House by Jan Schakowsky (D-Ill.) |